BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15202016)

  • 1. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
    Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
    Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation.
    Minchenko AG; Stevens MJ; White L; Abatan OI; Komjáti K; Pacher P; Szabó C; Obrosova IG
    FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats.
    Obrosova IG; Minchenko AG; Marinescu V; Fathallah L; Kennedy A; Stockert CM; Frank RN; Stevens MJ
    Diabetologia; 2001 Sep; 44(9):1102-10. PubMed ID: 11596663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.
    Chiu J; Xu BY; Chen S; Feng B; Chakrabarti S
    Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.
    Obrosova IG; Minchenko AG; Vasupuram R; White L; Abatan OI; Kumagai AK; Frank RN; Stevens MJ
    Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes.
    Xu B; Chiu J; Feng B; Chen S; Chakrabarti S
    Diabetes Metab Res Rev; 2008; 24(5):404-12. PubMed ID: 18351623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
    Guzyk MM; Tykhomyrov AA; Nedzvetsky VS; Prischepa IV; Grinenko TV; Yanitska LV; Kuchmerovska TM
    Neurochem Res; 2016 Oct; 41(10):2526-2537. PubMed ID: 27255598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats.
    Wang C; George B; Chen S; Feng B; Li X; Chakrabarti S
    Diabetes Metab Res Rev; 2012 May; 28(4):329-37. PubMed ID: 22228707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
    J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
    Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-Ribose) Polymerase Inhibition Improves Corneal Epithelial Innervation and Wound Healing in Diabetic Rats.
    Byun YS; Kang B; Yoo YS; Joo CK
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1948-55. PubMed ID: 25711635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
    Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
    Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy.
    Zhao HS; Shi XY; Wei WB; Wang NL
    Chin Med J (Engl); 2013; 126(9):1693-9. PubMed ID: 23652053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Poly(ADP-Ribose)Polymerase-1 Inhibitor 1,5-Isoquinolinediol Attenuate Diabetes-Induced NADPH Oxidase-Derived Oxidative Stress in Retina.
    Mohammad G; Alrashed SH; Almater AI; Siddiquei MM; Abu El-Asrar AM
    J Ocul Pharmacol Ther; 2018 Sep; 34(7):512-520. PubMed ID: 29912609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling protects retina from nuclear factor-κB- and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation.
    Qin X; Zhang Z; Xu H; Wu Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):703-11. PubMed ID: 21813561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP mediates structural alterations in diabetic cardiomyopathy.
    Chiu J; Farhangkhoee H; Xu BY; Chen S; George B; Chakrabarti S
    J Mol Cell Cardiol; 2008 Sep; 45(3):385-93. PubMed ID: 18657544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.